journal
MENU ▼
Read by QxMD icon Read
search

Journal of Substance Abuse Treatment

journal
https://www.readbyqxmd.com/read/28576389/healthcare-utilization-in-adults-with-opioid-dependence-receiving-extended-release-naltrexone-compared-to-treatment-as-usual
#1
William E Soares, Donna Wilson, Niels Rathlev, Joshua D Lee, Michael Gordon, Edward V Nunes, Charles P O'Brien, Peter D Friedmann
BACKGROUND: Opioid use disorders have reached epidemic proportions, with overdose now the leading cause of accidental death in the United States. Extended release naltrexone (XR-NTX) has emerged as a medication treatment that reduces opioid use and craving. However, the effect of XR-NTX therapy on acute healthcare utilization, including emergency department visits and inpatient hospitalizations, remains uncertain. The objective of the current study is to evaluate hospital-based healthcare resource utilization in adults involved in the criminal justice system with a history of opioid use disorder randomized to XR-NTX therapy compared with treatment as usual (TAU) during a 6-month treatment phase and 12months post-treatment follow up...
May 12, 2017: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/28527854/barriers-to-initiation-of-extended-release-naltrexone-among-hiv-infected-adults-with-alcohol-use-disorders
#2
Hélène Chokron Garneau, Alexandra Venegas, Richard Rawson, Lara A Ray, Suzette Glasner
Alcohol consumption is a major risk factor for the acquisition of HIV/AIDS and is associated with greater disease burden and mortality among those who become HIV-infected. Of the extant pharmacological treatments for alcohol use disorders, naltrexone is recognized as one of the most efficacious, producing robust reductions in alcohol craving and use. Given that treatment with oral naltrexone has been limited by problems with adherence, which are particularly prevalent among individuals with multiple chronic, co-occurring conditions, long-acting formulations may be a promising approach for HIV-infected substance users...
May 11, 2017: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/28487187/temporary-removal-a-randomized-trial-of-motivational-interviewing-for-the-prevention-of-underage-drinking-in-american-indian-adolescents
#3
David A Gilder, Jennifer R Geisler, Juan A Luna, Daniel Calac, Peter M Monti, Nichea S Spillane, Juliet P Lee, Roland S Moore, Cindy L Ehlers
The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the article will be specified, or the article will be reinstated. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.
April 23, 2017: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/28473233/relapse-to-opioid-use-disorder-after-inpatient-treatment-protective-effect-of-injection-naltrexone
#4
Edward V Nunes, Michael Gordon, Peter D Friedmann, Marc J Fishman, Joshua D Lee, Donna T Chen, Mei Chen Hu, Tamara Y Boney, Donna Wilson, Charles P O'Brien
BACKGROUND: Opioid use disorder is often treated with short term hospitalization and medically supervised withdrawal from opioids followed by counseling alone without medication assisted treatment (MAT). More evidence is needed to confirm the expectation that the rate of relapse would be high after short term inpatient treatment and withdrawal from opioids without follow-up MAT. OBJECTIVE/METHODS: To examine relapse to opioid use disorder in a randomized, multi-site effectiveness trial of extended-release injection naltrexone (XR-NTX) vs community-based treatment as usual (TAU) without medication, as a function of the type of clinical service where treatment was initiated-short-term inpatient (N=59), long-term inpatient (N=48), or outpatient (N=201)...
April 23, 2017: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/28449955/predictors-of-induction-onto-extended-release-naltrexone-among-unemployed-heroin-dependent-adults
#5
Brantley P Jarvis, August F Holtyn, Meredith S Berry, Shrinidhi Subramaniam, Annie Umbricht, Michael Fingerhood, George E Bigelow, Kenneth Silverman
BACKGROUND AND AIM: Extended-release naltrexone (XR-NTX) blocks the effects of opioids for 4weeks; however, starting treatment can be challenging because it requires 7 to 10days of abstinence from all opioids. In the present study we identified patient and treatment characteristics that were associated with successful induction onto XR-NTX. METHODS: 144 unemployed heroin-dependent adults who had recently undergone opioid detoxification completed self-report measures and behavioral tasks before starting an outpatient XR-NTX induction procedure...
April 20, 2017: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/28527855/initiation-of-extended-release-naltrexone-xr-ntx-for-opioid-use-disorder-prior-to-release-from-prison
#6
Peter D Friedmann, Donna Wilson, Randall Hoskinson, Michael Poshkus, Jennifer G Clarke
BACKGROUND: Opioid use disorder is common in prison populations, and prison release is a high-risk time for relapse and overdose. Initiation of extended release injectable naltrexone (XR-NTX)) prior to prison release might decrease relapse among opioid-dependent persons. OBJECTIVE: This pilot study examined the feasibility and acceptability of XR-NTX injection prior to prison release among adult inmates with opioid use disorder, followed by six months of community XR-NTX treatment...
April 19, 2017: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/28479011/extended-release-naltrexone-for-opioid-use-disorder-started-during-or-following-incarceration
#7
Thomas Lincoln, Benjamin D Johnson, Patrick McCarthy, Ellen Alexander
A western Massachusetts county jail began initiating extended-release naltrexone (XR-NTX) prior to release from incarceration and linking participants to community treatment providers upon release. Program barriers prevented the start of XR-NTX prior to release for a subset. METHODS: This report consists of the initial 67 jail releasees with opioid dependence, 47 who received XR-NTX before release, and 20 after release. Utility of the program was assessed by determining medication addiction treatment (MAT) retention rates at 4, 8, and 24 weeks...
April 6, 2017: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/28554608/documented-brief-intervention-not-associated-with-resolution-of-unhealthy-alcohol-use-one-year-later-among-va-patients-living-with-hiv
#8
Emily C Williams, Gwen T Lapham, Jennifer F Bobb, Anna D Rubinsky, Sheryl L Catz, Susan M Shortreed, Kara M Bensley, Katharine A Bradley
OBJECTIVE: Unhealthy alcohol use is particularly risky for patients living with HIV (PLWH). Brief interventions reduce drinking among patients with unhealthy alcohol use, but whether its receipt in routine outpatient settings is associated with reduced drinking among PLWH with unhealthy alcohol use is unknown. We assessed whether PLWH who screened positive for unhealthy alcohol use were more likely to resolve unhealthy drinking one year later if they had brief alcohol intervention (BI) documented in their electronic health record in a national sample of PLWH from the Veterans Health Administration...
July 2017: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/28554607/cardiorespiratory-fitness-and-body-composition-of-stimulant-users-a-baseline-analysis-of-the-stride-cohort
#9
Mark Stoutenberg, Chad D Rethorst, Denise C Vidot, Tracy L Greer, Madhukar H Trivedi
INTRODUCTION: Relatively little has been reported about the physical characteristics, such as cardiorespiratory fitness (CRF) and body composition, of stimulant users. Identifying risk factors associated with the physical health of stimulant users is an important public health issue as new treatments should better address the entire range of health concerns experienced by this population. METHODS: We examined cross-sectional data gathered at baseline from the STimulant Reduction Intervention using Dosed Exercise (STRIDE) study, a multisite randomized clinical trial that examined exercise as an adjunct to treatment as usual for individuals in residential treatment programs (RTPs)...
July 2017: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/28554606/a-randomized-trial-of-brief-assessment-interventions-for-young-adults-who-use-drugs-in-the-club-scene
#10
Steven P Kurtz, Mance E Buttram, Maria E Pagano, Hilary L Surratt
BACKGROUND: Efficacious interventions to reduce drug use and its consequences for club drug using populations are not apparent in the literature. We tested interviewer- (CAPI) and self-administered (ACASI) comprehensive health and social risk assessments as distinct interventions compared to waitlist control. METHODS: 750 men and women ages 18-39 with multidrug use and heterosexual behavior were randomized in equal proportions to the three conditions. Instrumentation included well-tested measures of drug use, risky sex, mental distress and substance dependence...
July 2017: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/28554605/corrigendum-to-timing-matters-a-randomized-control-trial-of-recovery-coaches-in-foster-care-journal-of-substance-abuse-treatment-77-2017-178-184
#11
Joseph P Ryan, Brian E Perron, Andrew Moore, Bryan G Victor, Keunhye Park
No abstract text is available yet for this article.
July 2017: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/28554604/how-online-counselling-can-support-partners-of-individuals-with-problem-alcohol-or-other-drug-use
#12
Samara R Wilson, Simone Rodda, Dan I Lubman, Victoria Manning, Marie B H Yap
BACKGROUND: Problematic alcohol and other drug (AOD) use impacts partners heavily, with an increased risk of experiencing domestic violence, financial stressors, health problems and relationship challenges. However, partners often do not seek help or support due to a range of barriers (e.g., shame, stigma, practical constraints). Online counselling may facilitate help-seeking by overcoming many of these barriers, however research is needed to explore what motivates partners to contact online counselling services, their experiences and needs, and how partners can be best supported online...
July 2017: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/28554603/association-between-executive-function-and-outcome-measure-of-treatment-in-therapeutic-community-among-cocaine-dependent-individuals
#13
Esperanza Vergara-Moragues, Antonio Verdejo-García, Oscar M Lozano, Sandra Santiago-Ramajo, Francisco González-Saiz, Patricia Betanzos Espinosa, Miguel Pérez García
The aim of this study was to examine the association between baseline executive functioning and outcome measure of treatment in 226 cocaine dependent individuals who initiated treatment in therapeutic communities TCs. The study was conducted across six TCs located in the region of Andalusia (southern Spain). Neuropsychological testing included tests of working memory, reasoning, inhibition, switching, attention interference and decision making. The outcome measures were type of discharge (treatment dropout vs...
July 2017: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/28554602/the-relationship-between-diversion-related-attitudes-and-sharing-and-selling-buprenorphine
#14
Shannon R Kenney, Bradley J Anderson, Genie L Bailey, Michael D Stein
OBJECTIVE: Buprenorphine medication-assisted treatment (B-MAT) is an efficacious and popular outpatient treatment for opioid use disorder. However, the likelihood of buprenorphine diversion is a public health concern. We examined the relationship between attitudes toward diversion as predictors of both sharing and selling buprenorphine. METHOD: Participants (n=476) were patients undergoing short-term inpatient opioid detoxification. Multinomial logistic regression was used to estimate the adjusted association of sharing and selling buprenorphine with demographics, substance use behaviors, and attitudes toward sharing and selling buprenorphine...
July 2017: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/28554601/hepatitis-c-virus-core-antigen-a-potential-alternative-to-hcv-rna-testing-among-persons-with-substance-use-disorders
#15
Andrew H Talal, Yang Chen, Marija Zeremski, Roberto Zavala, Clewert Sylvester, Mary Kuhns, Lawrence S Brown, Marianthi Markatou, Gavin A Cloherty
BACKGROUND: The hepatitis C virus (HCV) core antigen (HCVcAg) may be an alternative diagnostic method to HCV RNA especially in populations such as substance users, the homeless or in resource-limited settings. AIMS: To evaluate performance of HCVcAg test in patients with opioid use disorder (OUD) on methadone in order to document its performance characteristics in the target population and to ensure that its specificity remains consistent across different populations...
July 2017: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/28554600/gratitude-abstinence-and-alcohol-use-disorders-report-of-a-preliminary-finding
#16
Amy R Krentzman
Gratitude is a central component of addiction recovery for many, yet it has received scant attention in addiction research. In a sample of 67 individuals entering abstinence-based alcohol-use-disorder treatment, this study employed gratitude and abstinence variables from sequential assessments (baseline, 6months, 12months) to model theorized causal relationships: gratitude would increase pre-post treatment and gratitude after treatment would predict greater percent days abstinent 6months later. Neither hypothesis was supported...
July 2017: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/28554599/pharmacokinetics-and-pharmacodynamics-of-a-buprenorphine-subcutaneous-depot-formulation-cam2038-for-once-weekly-dosing-in-patients-with-opioid-use-disorder
#17
Christian Haasen, Margareta Linden, Fredrik Tiberg
INTRODUCTION: Sublingual buprenorphine is effective for opioid dependence treatment but associated with misuse, abuse, and diversion. The present Phase I/II study evaluated a novel buprenorphine subcutaneous depot formulation for once-weekly dosing (CAM2038 q1w) in patients receiving maintenance treatment for opioid use disorder with daily sublingual buprenorphine. METHODS: After discontinuation of buprenorphine for 48h, patients received a single CAM2038 q1w dose based on their pre-study daily sublingual maintenance dose...
July 2017: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/28554598/baseline-risk-factors-for-drug-use-among-african-american-patients-during-first-month-induction-stabilization-on-methadone
#18
Jamey J Lister, Mark K Greenwald, David M Ledgerwood
Drug use during methadone induction/stabilization negatively influences later methadone-maintenance-treatment [MMT] outcomes (retention, abstinence). Our study examined the association of baseline risk factors to drug use during the first month of methadone treatment as well as longer-term treatment retention. We conducted these analyses among a race/ethnic minority group at high risk for worse MMT outcomes. African-American MMT patients (N=212) were interviewed at intake to assess clinical (drug use history), psychosocial (close family member substance abuse, psychosocial problems), and demographic factors...
July 2017: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/28554597/why-aren-t-physicians-prescribing-more-buprenorphine
#19
Andrew S Huhn, Kelly E Dunn
BACKGROUND & OBJECTIVE: Buprenorphine is an underutilized pharmacotherapy that can play a key role in combating the opioid epidemic. Individuals with opioid use disorder (OUD) often struggle to find physicians that prescribe buprenorphine. Many physicians do not have the waiver to prescribe buprenorphine, and a large proportion of physicians that are waivered do not prescribe to capacity. This study aimed to quantitatively understand why physicians do not utilize buprenorphine for the treatment of OUD more frequently...
July 2017: Journal of Substance Abuse Treatment
https://www.readbyqxmd.com/read/28476279/medical-cannabis-use-among-patients-with-chronic-pain-in-an-interdisciplinary-pain-rehabilitation-program-characterization-and-treatment-outcomes
#20
Arya Shah, Julia Craner, Julie L Cunningham
INTRODUCTION: Cannabis is increasingly being used in the treatment of chronic pain. However, there is a lack of available research in the population of patients with chronic pain who are using cannabis. The current study examines clinical and treatment characteristics for patients who are admitted to a 3-week outpatient interdisciplinary chronic pain rehabilitation program. METHOD: Participants (N=48) included patients with a positive urine drug screen for 9-carboxy-tetrahydrocannabinol (THC(+); n=24) and a matched comparison sample of patients with a negative screen (THC(-); n=24)...
June 2017: Journal of Substance Abuse Treatment
journal
journal
28942
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"